Two Sigma Ventures
Latest statistics and disclosures from Two Sigma Ventures's latest quarterly 13F-HR filing:
- Top 5 stock holdings are RXRX, and represent 100.00% of Two Sigma Ventures's stock portfolio.
- Reduced shares in these 2 stocks: RXRX (-$9.6M), Zymergen.
- Sold out of its position in Zymergen.
- Two Sigma Ventures was a net seller of stock by $-12M.
- Two Sigma Ventures has $9.6M in assets under management (AUM), dropping by -41.99%.
- Central Index Key (CIK): 0001878979
Tip: Access up to 7 years of quarterly data
Positions held by Two Sigma Ventures consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Two Sigma Ventures
Two Sigma Ventures holds 1 positions in its portfolio as reported in the September 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Recursion Pharmaceuticals In Cl A (RXRX) | 100.0 | $9.6M | -50% | 903k | 10.64 |
|
Past Filings by Two Sigma Ventures
SEC 13F filings are viewable for Two Sigma Ventures going back to 2021
- Two Sigma Ventures 2022 Q3 filed Nov. 14, 2022
- Two Sigma Ventures 2022 Q2 filed Aug. 15, 2022
- Two Sigma Ventures 2022 Q1 filed May 16, 2022
- Two Sigma Ventures 2021 Q4 filed Feb. 14, 2022